Clinical Trial

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This clinical research study is testing the study compound petrelintide that is being developed for the weight management in people with obesity or overweight with comorbidities or related diseases. The aim of this clinical research study is to investigate whether the effects of petrelintide will be different in people with normal kidney function compared to people with impaired kidney function.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-07-10; most recent amendment 2026-01-27.
Status change: Recruiting → Completed 2026-01-13
Trial Details
NCT Number NCT07076030
Lead Sponsor Zealand Pharma
Collaborators: ICON plc
Conditions Renal Impairment
Enrollment 39 participants
Start Date 2025-04-15
Primary Completion 2025-11-25 (estimated)
Study Completion 2025-11-25 (estimated)
Updated on ClinicalTrials.gov 2026-01-28